A phase I study of AB 101 (Insulin) in patients with type 2 diabetes mellitus
Phase of Trial: Phase I
Latest Information Update: 07 Dec 2017
At a glance
- Drugs Insulin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions
- 07 Dec 2017 According to a AntriaBio media release, AntriaBio changed its name to Rezolute.
- 10 Dec 2015 According to a media release, AntriaBio will use the proceeds from a private placement transaction for phase I trials of AB101 in patients with type 1 and type 2 diabetes.
- 19 Nov 2015 New trial record